Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
India GLP-1 Receptor Agonists Obesity Drugs Market Insight The India GLP-1 receptor agonists obesity drugs accounted for the largest revenue share in Asia Pacific in 2024, driven by a growing obesity burden, increasing healthcare awareness, and the rapid expansion of urban healthcare infrastructure
Vukovich, MD
J., & Wisco, O
Is your primary challenge losing weight, or is it optimizing body composition and performance
Thigh: Upper Arm: This site may require assistance from a caregiver for proper administration
US$ 28.01
US$ 20.40
US$ 25.39
US$ 22.08
US$ 21.22
US$ 21.23
